Retrospective Evaluation of Mycoplasma Genitalium Prevalence and Macrolide Resistance in a Study Cohort of Pregnant Women in Birmingham, AL, From 1997 to 2001
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
In a prospective study conducted in 2020 to 2021, macrolide resistance-associated mutations were found in 41% of pregnant persons in Birmingham, AL, with Mycoplasma genitalium detected. We retrospectively evaluated M. genitalium in 203 pregnant persons participating in a study conducted in 1997 to 2001 in Birmingham and adjacent areas and found a prevalence of 11% (95% confidence interval, 6.9%-15.7%), but no macrolide resistance-associated mutations.
References
1.
Jensen J, Bradshaw C, Tabrizi S, Fairley C, Hamasuna R
. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis. 2008; 47(12):1546-53.
DOI: 10.1086/593188.
View
2.
Salado-Rasmussen K, Jensen J
. Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis. 2014; 59(1):24-30.
PMC: 4305131.
DOI: 10.1093/cid/ciu217.
View
3.
Klein E, Milkowska-Shibata M, Tseng K, Sharland M, Gandra S, Pulcini C
. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data. Lancet Infect Dis. 2020; 21(1):107-115.
DOI: 10.1016/S1473-3099(20)30332-7.
View
4.
Xiao L, Waites K, Wang H, Van Der Pol B, Ratliff A, Geisler W
. Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimens. Diagn Microbiol Infect Dis. 2018; 91(2):123-125.
PMC: 5970045.
DOI: 10.1016/j.diagmicrobio.2018.02.002.
View
5.
Lau A, Bradshaw C, Lewis D, Fairley C, Chen M, Kong F
. The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. Clin Infect Dis. 2015; 61(9):1389-99.
DOI: 10.1093/cid/civ644.
View